It’s hard to imagine a more difficult path of aging. That makes the courage and compassion of families all the more inspiring ...

In the United States, 7.2 million people are currently living with Alzheimer’s, with over 5 million of them being over the ...

South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

British researchers said the findings, published in The Lancet Psychiatry, could give doctors a potential tool to spot those ...

A new multicenter study led by Mayo Clinic researchers has established a practical, evidence-based definition of rapidly ...

A new study suggests that hydrogen sulfide, a gas released by the body when you fart, could help protect the brain against ...

A drug approved to help slow the progression of Alzheimer’s is giving an Oklahoma couple hope. The drug is only for patients ...

New research shows that where a person lives can determine whether they receive timely diagnosis and care, or instead fall ...

Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...

Dementia is a group of disorders that gradually impair memory, thinking and daily functioning. Alzheimer's disease (AD), the ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...